I have noticed a promising trend the rise of open source drug R&d consortia that include large biotech
generating creative initiatives from universities, tech transfer organizations, government and biotechs. BIO-X is an open innovation vehicle run by Uppsala BIO.
and small biotechs, offering to support their ideas through to proof of principle. or the proposals selected,
#Biotechnology Helps Meet Consumer Demand for Earth-Friendly Products Industrial biotechnology has its roots in cleaning up environmental hazards.
Today, biotechnology enables manufacturers to make sustainable products with renewable material, instead of oil, and to use less energy in the manufacturing process A recent Roundtable discussion hosted by the Industrial biotechnology Journal
Advances such as this show the promise of biotechnology to transform lives and enable patients who had relied previously on frequent,
Alicia Jackson, the deputy director of Darpa Biological Technologies Office In virginia, made comments alluding to the technology at a biotech conference on Monday. or the first time
and a Biotechnology and Biological sciences Research Council award, was published in the Science Translational Medicine journal in April.
A few years back while working as a postdoc in Vienna at the Institute of Molecular Biotechnology (IMBA
Implantable Drug Releasing Microchips Over the past few years wee covered Microchips Biotech, an MIT spin out company that developed an implantable technology to release drugs inside the body in a controlled manner.
Courtesy of SQZ Biotech) We wanted to remove an important barrier in using B cells as an antigen-presenting cell population,
Courtesy of SQZ Biotech) Through Cellsqueeze, the device platform originally developed at MIT, the researchers pass a suspension of B cells and target antigen through tiny, parallel channels etched on a chip.
After developing Cellsqueeze at MIT, Sharei co-founded SQZ Biotech in 2013 to further develop and commercialize the platform.
Meanwhile, SQZ Biotech aims to reduce the footprint of its device, which could potentially lower the time
Since the advent of biotechnology, researchers have modified bacteria to produce therapeutic drugs or antibiotics. In this novel study
Earlier this month, MIT spinout Microchips Biotech partnered with a pharmaceutical giant to commercialize its wirelessly controlled, implantable,
Invented by Microchips Biotech cofounders Michael Cima, the David H. Koch Professor of Engineering, and Robert Langer, the David H. Koch Institute Professor, the microchips consist of hundreds of pinhead-sized reservoirs,
and osteoporosis. Michael Cima (left) and Robert Langer Now Microchips Biotech will begin co-developing microchips with Teva Pharmaceutical, the worlds largest producer of generic drugs,
Apart from providing convenience, Microchips Biotech says these microchips could also improve medication-prescription adherence a surprisingly costly issue in the United states. A 2012 report published in the Annals of Internal medicine estimated that Americans who dont stick to prescriptions rack up $100 billion
Microchips Biotech will continue work on its flagship product, a birth-control microchip, backed by the Bill and Melinda Gates Foundation,
Cima, who now serves on the Microchips Biotech board of directors with Langer sees this hormone-releasing microchip as one of the first implantable artificial organs because it acts as a gland.
A version of Microchip Biotech's implantable, wirelessly controlled microchip. When an electrical current is delivered to one of the chip's tiny reservoirs,
For years, the technology underwent rigorous research and development at Microchips Biotech. But in 2011, Langer and Cima,
MEMS innovations Microchips Biotech made several innovations in the microelectromechanical systems (MEMS) manufacturing process to ensure the microchips could be commercialized.
To do so, Microchips Biotech modified a cold-welding tongue and groove process. This meant depositing a soft,
which was published in Frontiers in Bioengineering and Biotechnology("Lauric acid production in a glycogen-less strain of Synechococcus sp.
and uses biotechnology to convert viruses into therapeutic agents, effectively allowing them to go on seek
It was funded by Asthma UK, the Cardiff Partnership Fund, Marie Curie Initial Training Network, the Biotechnology and Biological sciences Research Council and the US National institutes of health t
"The ability to deliver molecules into adherent cells without disrupting differentiation is needed for biotechnology researchers to advance both fundamental knowledge and the state-of-the-art in stem cell research,
From 1994 to 2004 the medical device biotechnology and pharmaceutical industries had annual growth rates greater than 6 percent per year with biotechnology demonstrating the largest increases.
The approach opens up new possibilities for the study of biomedical processes as well as for applications in biotechnology, chemistry, and pharmacy."
This is a fundamentally new approach for biology, biotechnology, and medicine,"says Schiller. With the help of chemical reactions that were previously impossible in the cell,
Schilller was awarded the research prize"Next Generation of Biotechnological Methods--Biotechnology 2020+"from the Federal Ministry of Education
an urban research and business park specializing in biotechnology, materials science and information technology. Wake Forest Baptist clinical, research and educational programs are ranked annually among the best in the country by U s. News & World Report u
Since the advent of biotechnology, researchers have modified bacteria to produce therapeutic drugs or antibiotics. In this novel study, they have actually become a diagnostic tool.
Professor Thomas is working on a delivery technology with Dendright Pty Ltd (a Uniquest start-up company) in collaboration Janssen Biotech Inc,
'The research was supported by Cancer Research UK, the Wellcome Trust and the Biotechnology and Biological sciences Research Council UK K
and biotechnology can join forces
#Fundamental beliefs about atherosclerosis overturned"The leading cause of death worldwide is complications of atherosclerosis,
#Novel glycoengineering technology gives qualitative leap for biologics drug research Researchers from the University of Copenhagen have discovered a way of improving biotech drugs.
Nature Biotechnology. If glycoprotein-based pharmaceuticals are to produce the desired effect, the protein must be provided with a special sugar structure for enhanced therapeutic effect and duration.
for context, only 108 mammals are listed in the National Center for Biotechnology Information database. ntil recently,
is likely to pave the way for the development of a wide range of new biotechnologies.
The research was supported by Cancer Research UK, the Wellcome Trust and the Biotechnology and Biological sciences Research Council UK e
UW-Madison has opened a genome editing facility in its Biotechnology Center. e want the whole campus to utilize this technology,
#TSRI and Biotech Partners Find New Antibody Weapons against Marburg virus A new study led by scientists at The Scripps Research Institute (TSRI) identifies new immune molecules that protect against deadly Marburg virus, a relative
according to a study published today (June 15) in Nature Biotechnology. his is an effective new system for extremely precise control of gene editing via light, Paul Knoepfler, a stem cell biologist at the University of California, Davis,
hotoactivatable CRISPR-Cas9 for optogenetic genome editing, Nature Biotechnology, doi: 10.1038/nbt. 3245,2015 d
#Tasty Visuals To help those with visual impairments make out the shape and movement of objects, a company has developed a device that takes visual information
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011